infinitesimal LLC. is privileged to be one of eight companies that will take part in Innovation AveNew at the upcoming Society for Laboratory Automation and Screening (SLAS) conference. SLAS 2017 will be held from February 4th – 8th at the Walter E. Washington Convention Center in Washington, D.C.
infinitesimal was selected to participate in Innovation AveNew by a committee of judges based on the following criteria: impact of the technology, commercial viability, and potential impact on the field of laboratory automation and technology. The goal of Innovation AveNew is to provide life science start-up companies with tremendous exposure and support including dedicated exhibit space at this prestigious international scientific conference. Additionally, infinitesimal will be delivering a presentation at SLAS 2017 on Tuesday, February 7th from 4:00-4:30 pm as part of the Making Micro-Volume Biology Work: Tools, Techniques & Secrets sessions.
The lecture is titled “Monoclonal Cell Line Generation and CRISPR/Cas9 Gene Knockout using Automated Single-Cell Electroporation” and will discuss techniques possible using infinitesimal’s NFP- E™ technology.
To those attending SLAS2017, be sure to check out infinitesimal as part of Innovation AveNew and on stage to learn more about the company and see a demo of the NFP-E™ technology that earned them this impressive distinction. For further information, please contact Horacio Espinosa, President and Founder of infinitesimal, via e-mail at email@example.com
Distributed by PREngine
Company Name: infinitesimal LLC.
Contact Person: Horacio Espinosa
Country: United States